Prognostic effect of serum and tissue YKL-40 levels in bladder cancer.

MLA

Tschirdewahn, Stephan, et al. “Prognostic Effect of Serum and Tissue YKL-40 Levels in Bladder Cancer.” Urologic Oncology, vol. 32, no. 5, July 2014, pp. 663–69. EBSCOhost, https://doi.org/10.1016/j.urolonc.2014.02.004.

APA

Tschirdewahn, S., Reis, H., Niedworok, C., Nyirady, P., Szendröi, A., Schmid, K. W., Shariat, S. F., Kramer, G., vom Dorp, F., Rübben, H., & Szarvas, T. (2014). Prognostic effect of serum and tissue YKL-40 levels in bladder cancer. Urologic Oncology, 32(5), 663–669. https://doi.org/10.1016/j.urolonc.2014.02.004

Chicago

Tschirdewahn, Stephan, Henning Reis, Christian Niedworok, Peter Nyirady, Attila Szendröi, Kurt W Schmid, Shahrokh F Shariat, et al. 2014. “Prognostic Effect of Serum and Tissue YKL-40 Levels in Bladder Cancer.” Urologic Oncology 32 (5): 663–69. doi:10.1016/j.urolonc.2014.02.004.